Zhongchao (ZCMD) Gains from Investment Securities (2022 - 2023)
Zhongchao (ZCMD) reported Gains from Investment Securities of $1800.0 for Q4 2023, little changed year-over-year from $1800.0 in Q4 2022, and little changed quarter-over-quarter from $1800.0 in Q4 2022.
Zhongchao (ZCMD) Gains from Investment Securities (2022 - 2023) Analysis & Trends
Zhongchao (ZCMD) has 2 years of Gains from Investment Securities data on file, last reported at $1800.0 in Q4 2023.
- Gains from Investment Securities for Q4 2023 came in at $1800.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2023 was $1800.0 (changed 0.0% YoY), and the FY2025 annual result was -$24531.0, down 153.39% from the prior year.
- Gains from Investment Securities was little changed at $1800.0 in Q4 2023 per ZCMD's latest filing, from $1800.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1800.0 in Q4 2022 and troughed at $1800.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn |
| 10 | Zhongchao | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,800.00 |
| Dec 31, 2023 | 1,800.00 |
| Dec 31, 2022 | 1,800.00 |
| Dec 31, 2022 | 1,800.00 |